Skip to main content
XRTX
NASDAQ Life Sciences

XORTX Q3 Interim Report: Going-Concern Warning, $318,846 Cash, Material Weakness Persists

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.011
Mkt Cap
$1.998M
52W Low
$0.815
52W High
$3.6
52W Position info
24% above low
Off High info
72% below high
Rel. Volume info
2.1× avg
Market data snapshot near publication time

XRTX sits 24% above its 52-week low of $0.815 on elevated volume (2.1× avg).

Summary

XORTX reported $318,846 of cash at September 30, 2026 against a ~$282,000 monthly burn and repeated its going-concern warning, while disclosing that its material weakness in internal controls remains unremediated.


Key Events · Earnings and Guidance · XRTX

  • Going-Concern Warning Reiterated

    Note 1 states conditions indicate a material uncertainty that casts significant doubt about the Company's ability to continue as a going concern.

  • Cash Down to $318,846

    Cash fell from $864,514 at December 31, 2025 to $318,846 at September 30, 2026; MD&A puts current cash burn at approximately $282,000 per month excluding IR activities.

  • Nine-Month Loss Widens

    Net loss was $2,881,306 ($1.79 per share) versus $2,065,842 ($2.50 per share) a year earlier, with investor relations expense of $1,011,044 in the period.

  • Material Weakness Not Remediated

    Management determined DC&P and ICFR were not effective at September 30, 2026 because of a material weakness in the period-end closing process and related review controls; remediation steps are not yet operating effectively.


Analysis · XRTX · Life Sciences

With $318,846 of cash at September 30, 2026 and a burn of roughly $282,000 a month, XORTX is measuring its runway in weeks, not quarters — and management states plainly that conditions raise significant doubt about the company's ability to continue as a going concern. The nine-month loss widened to $2,881,306 from $2,065,842 a year earlier, driven largely by a $1,011,044 investor relations charge tied to the IR Agency LLC agreement. Gross proceeds from the May 2026 offering were $4,999,999, but issuance costs consumed $961,720, and most of the securities sold were pre-funded warrants at $0.0001 — 2,996,147 of them still outstanding at period end, plus 344,000 exercised after the quarter for $34. On top of that, management says the previously identified material weakness in the period-end closing process is not yet operating effectively, so disclosure controls and ICFR were again deemed not effective. New financing is needed before the XRx-026 IND and the XRX-OXY-102 study can proceed.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XRTX was trading at $1.01 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $2M. The 52-week trading range was $0.82 to $3.60. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XRTX - Latest Insights

XRTX
Oct 08, 2026, 4:00 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $2.33
Real-time Price: $1.01 info
Change: -$1.32 (-57%) info
Market Cap: $1.998M info
XRTX
Sep 18, 2026, 8:05 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $1.76
Real-time Price: $1.01 info
Change: -$0.7544 (-43%) info
Market Cap: $1.998M info
XRTX
Sep 18, 2026, 8:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.68
Real-time Price: $1.01 info
Change: -$0.670 (-40%) info
Market Cap: $1.998M info
XRTX
Sep 04, 2026, 8:51 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $2.39
Real-time Price: $1.01 info
Change: -$1.38 (-58%) info
Market Cap: $1.998M info
XRTX
Aug 28, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $2.44
Real-time Price: $1.01 info
Change: -$1.43 (-59%) info
Market Cap: $1.998M info